Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Photochem Photobiol ; 99(6): 1468-1475, 2023.
Article in English | MEDLINE | ID: mdl-36773299

ABSTRACT

Cervical carcinoma (CC) is the second cause of cancer death in Mexican women. It starts with premalignant lesions known as Intraepithelial Cervical Neoplasia (CIN) that can develop due to infection by Human Papillomavirus (HPV) and other microorganisms. Current CIN therapy involves invasive methods that affect cervix integrity and fertility; we propose the use of photodynamic therapy (PDT) as a strategy with few side effects. In this work, the effectiveness of PDT for CIN I, HPV and pathogenic vaginal microbiota elimination in 29 women of Mexico City with CIN I, CIN I + HPV and HPV diagnosis was determined. After 6 months of PDT application, HPV infection was eliminated in 100% of the patients (P < 0.01), CIN I + HPV in 64.3% (P < 0.01) and CIN I in 57.2% (P > 0.05). PDT also eliminated pathogenic microorganisms: Chlamydia trachomatis in 81% of the women (P < 0.001) and Candida albicans in 80% (P < 0.05), without affecting normal microbiota since Lactobacillus iners was eliminated only in 5.8% of patients and the opportunistic Gardnerella vaginalis in 20%. These results show that PDT was highly effective in eradicating HPV and pathogenic microorganisms, suggesting that PDT is a promising therapy for cervical infections.


Subject(s)
Microbiota , Papillomavirus Infections , Photochemotherapy , Uterine Cervical Dysplasia , Uterine Cervical Neoplasms , Humans , Female , Cervix Uteri/pathology , Human Papillomavirus Viruses , Papillomavirus Infections/drug therapy , Mexico , Uterine Cervical Dysplasia/drug therapy , Uterine Cervical Neoplasms/drug therapy , Uterine Cervical Neoplasms/pathology , Photochemotherapy/methods
2.
Anticancer Res ; 40(11): 6273-6284, 2020 Nov.
Article in English | MEDLINE | ID: mdl-33109565

ABSTRACT

BACKGROUND/AIM: To determine the differential protein profiles of cervical cancer cell lines in order to find potential targets that can be used as biomarkers in low-grade squamous intraepithelial lesions (LSIL) diagnosis. MATERIALS AND METHODS: Proteomic analysis was performed on cervical cancer cell lines by 2D electrophoresis and liquid chromatography-mass spectrometry. Biomarker validation was performed in histological samples by immunofluorescence. RESULTS: Aldo-keto reductase C1 (AKR1C1) and transketolase-like 1 (TKTL1) proteins were selected as biomarkers and their expression was increased in samples with LSIL diagnosis. TKTL1 in combination with AKR1C1 increased sensitivity and specificity to 75% and 66%, respectively, with an area under curve of 0.76 in receiver operating characteristics curve analysis. CONCLUSION: AKR1C1 and TKTL1 showed potential as biomarkers for diagnosis of LSIL in Mexican women, with similar sensitivity and specificity to the biomarkers used in clinical trials for diagnosis of LSIL.


Subject(s)
20-Hydroxysteroid Dehydrogenases/metabolism , Squamous Intraepithelial Lesions/diagnosis , Squamous Intraepithelial Lesions/metabolism , Transketolase/metabolism , Uterine Cervical Dysplasia/diagnosis , Uterine Cervical Dysplasia/metabolism , Adult , Area Under Curve , Cell Line, Tumor , Female , Humans , Mexico , Neoplasm Grading , Neoplasm Proteins/metabolism , Protein Interaction Maps , ROC Curve , Squamous Intraepithelial Lesions/pathology , Uterine Cervical Dysplasia/pathology
3.
Photochem Photobiol ; 93(5): 1269-1275, 2017 10.
Article in English | MEDLINE | ID: mdl-28380684

ABSTRACT

This study aimed to determine the effectiveness of photodynamic therapy (PDT), using δ-aminolevulinic acid (5-ALA), in the elimination of premalignant cervical lesions in Mexican patients with human papillomavirus (HPV) infection and/or cervical intraepithelial neoplasia (CIN). Thirty women diagnosed with CIN I and/or positive for HPV participated in the study. Topical 6% 5-ALA in gel form was applied to the uterine cervix; after 4 h, the lesion area was irradiated with a light dose of 200 J cm-2 at 635 nm. This procedure was performed three times at 48-h intervals. Clinical follow-up was performed at 3, 6, and 12 months after the initial PDT administration, by colposcopy, cervical cytology, histopathological analysis, polymerase chain reaction, and hybrid capture. Of HPV-infected patients without evidence of CIN I, 80% cleared the infection, while HPV associated with CIN I was eliminated in 83% of patients (P < 0.05). At 12 months, CIN I had regressed in 57% of patients, although this response was not statistically significant. PDT using 6% 5-ALA is concluded to be effective in eliminating HPV infection associated or not with CIN I.


Subject(s)
Aminolevulinic Acid/therapeutic use , Human papillomavirus 16/drug effects , Human papillomavirus 18/drug effects , Papillomavirus Infections/drug therapy , Papillomavirus Infections/virology , Photochemotherapy/adverse effects , Photosensitizing Agents/therapeutic use , Uterine Cervical Dysplasia/drug therapy , Adult , Aminolevulinic Acid/pharmacology , Female , Humans , Mexico , Photosensitizing Agents/pharmacology , Treatment Outcome , Uterine Cervical Dysplasia/virology
SELECTION OF CITATIONS
SEARCH DETAIL
...